Hims & Hers Introduces MedMatch, The Next Generation of Intelligent  Diagnostic Services

Hims & Hers Introduces MedMatch, The Next Generation of Intelligent Diagnostic Services

4.8
(324)
Write Review
More
$ 36.50
Add to Cart
In stock
Description

SAN FRANCISCO, November 06, 2023--Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS), the leading health and wellness platform, today introduced MedMatch, a technology designed to transform healthcare by giving providers a more intelligent and informed way to deliver personalized care to patients with more effective and precise treatments and medications.
SAN FRANCISCO, November 06, 2023--Hims & Hers Health, Inc. (Hims & Hers or the Company) (NYSE: HIMS), the leading health and wellness platform, today

Telehealth News Recap - Dec 2023

Cadence Unleashes the Future of Analog, Custom and RFIC Design

Cotação Hims and Hers Health - HIMS, Ações New York Stock Exchange

Stock Market News 2023-11-06

Hims & Hers Health Stock (NYSE:HIMS), Quotes and News Summary - Benzinga

Marruecos elimina a Portugal a puro fútbol 1-0 archivos - Metro

INEOS, partners invest $61,500 into Danbury ISD's future

Exclusive Q&A: Hims & Hers on its proprietary EMR and new AI-enabled MedMatch

Hims launches Hers, a telemedicine brand for women's health

Hims & Hers Health Stock (NYSE:HIMS), Quotes and News Summary - Benzinga

Committee defers decision on Russia CDS auction after U.S. sanctions update

Dedicated CPS workers earn praise, Brazos Living

Hims & Hers Unveils MedMatch in a Bid to Advance Personalized Healthcare Through AI

C.H. Robinson Appoints Dave Bozeman Chief Executive Officer Seite

Hims & Hers Health, Inc., TalkMarkets